Bristol-Myers Squibb

Bristol-Myers, Pfizer come up victorious in 20 more Eliquis bleeding cases
Fierce Pharma
Tue, 08/1/17 - 10:58 am
Bristol-Myers Squibb
Pfizer
Eliquis
bloodthinners
Why Clovis Oncology Tumbled 13.5% Today
Motley Fool
Mon, 07/31/17 - 09:58 pm
Clovis Oncology
Rubraca
Bristol-Myers Squibb
Bristol-Myers and Clovis will partner for cancer combination trials
Marketwatch
Mon, 07/31/17 - 10:07 am
clinical trials
Bristol-Myers Squibb
Clovis Oncology
Opdivo
Rubraca
Bristol shrugs off comparisons to MYSTIC
BioPharma Dive
Fri, 07/28/17 - 11:38 am
AstraZeneca
Bristol-Myers Squibb
Mystic
immuno-oncology
Opdivo
AstraZeneca Cancer Drug Failure Doesn't Bode Well For Bristol Myers
TheStreet.com
Thu, 07/27/17 - 11:07 am
AstraZeneca
clinical trials
Mystic
Bristol-Myers Squibb
Opdivo
These 2 Pharma Giants May Be on Pfizer's M&A Radar Right Now
Motley Fool
Wed, 07/26/17 - 11:22 am
Pfizer
M&A
AstraZeneca
Bristol-Myers Squibb
FDA Considers Label Changes for Keytruda, Opdivo and Yervoy
RAPS.org
Wed, 07/12/17 - 02:41 pm
FDA
labeling
Keytruda
Opdivo
Yervoy
immuno-oncology
Merck
Bristol-Myers Squibb
Bristol-Myers Squibb adds new fundraising options, celeb partners to 'Ready. Raise. Rise.' I-O push
Fierce Pharma
Wed, 07/12/17 - 10:46 am
Bristol-Myers Squibb
immuno-oncology
celebrity endorsements
Exelixis & Bristol-Myers Initiate Trial on Opdivo-Cabometyx
Yahoo/Zacks.com
Wed, 07/12/17 - 10:05 am
Exelixis
Bristol-Myers Squibb
clinical trials
Opdivo
Opdivo-Cabometyx
renal cell carcinoma
Big Pharma share prices jumped in the first half, except for BMS
Fierce Pharma
Wed, 07/12/17 - 12:10 am
Big Pharma
pharma stocks
Bristol-Myers Squibb
These 5 Cancer Drugs Will Be the Biggest Winners 5 Years From Now
Motley Fool
Mon, 07/10/17 - 11:34 pm
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
AbbVie
JNJ
Imbruvica
Pfizer
Ibrance
cancer
What the FDA's Hold on Three Merck Studies Means for Other Drug Makers
TheStreet.com
Sun, 07/9/17 - 07:44 pm
Merck
Keytruda
FDA
clinical trials
Multiple Myeloma
Bristol-Myers Squibb
AstraZeneca
Celgene
Prescribed Reading: I/O is the only game in town
BioPharma Dive
Sat, 07/8/17 - 10:02 am
immuno-oncology
Celgene
BeiGene
Endo International
Opana ER
Novartis
Orkambi
Vertex Pharmaceuticals
Merck
Bristol-Myers Squibb
Roche
Opdivo
Keytruda
Orencia
Bristol Myers Vies to Be King of Immuno-Boosting Cancer Drugs with New Trial Update
TheStreet.com
Thu, 07/6/17 - 09:41 am
Bristol-Myers Squibb
Opdivo
melanoma
Medical device makers look to slip lawsuits on Supreme Court ruling
Mass Device
Wed, 07/5/17 - 06:59 pm
devices
Supreme Court
St. Jude Medical
Boston Scientific
JNJ
Ethicon
Bristol-Myers Squibb
Bristol-Myers’ tarnished checkpoint star Opdivo beats out Yervoy in surprise PhIII
Endpoints
Wed, 07/5/17 - 10:00 am
Bristol-Myers Squibb
Opdivo
Yervoy
melanoma
2 Pharma Buyout Targets That May Surprise You
Motley Fool
Tue, 06/27/17 - 09:46 am
Biogen
Bristol-Myers Squibb
M&A
MS
multiple sclerosis
immuno-oncology
Standing out in crowded cancer market
Medical Marketing and Media
Mon, 06/26/17 - 10:36 pm
cancer
Opdivo
Bristol-Myers Squibb
After Bristol-Myers Squibb's Supreme Court win, Johnson & Johnson seeks relief from $300M in talc verdicts
Fierce Pharma
Wed, 06/21/17 - 10:58 am
Bristol-Myers Squibb
JNJ
patients
Supreme Court
5 Most Profitable Big Pharma Stocks on the Market Right Now
Motley Fool
Wed, 06/21/17 - 09:37 am
Big Pharma
Gilead Sciences
Amgen
Novartis
Biogen
Bristol-Myers Squibb

Pages